# Poseida Therapeutics funding: rounds and investors > Poseida Therapeutics has raised $217M across 3 rounds since 2019. Investors include Fidelity, Perceptive Advisors and Vivo Capital. Every round with its source. Source: https://millionrounds.com/company/poseida-therapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Poseida Therapeutics* 3 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Pharma Funding summary Updated 26 Oct 2026 **$217M** raised across 3 rounds since 2019, from 3 sources **$142M** Series C **$25M** Round **$50M** Round - **Latest round:** Round, $25M Aug 2023 - **Biggest round:** $142M Series C · Apr 2019 - **Investors:** 13 (1 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2020 2021 2022 2023 **$142M** Series C **$25M** Round **$50M** Round - **First round:** Series C, $142M - **Biggest round:** $142M - **Between rounds:** 4.3 years ## The rounds - **Aug 2023** Round **$25M** *4 new* *1 returning* [Fidelity](https://millionrounds.com/fund/fidelity) [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [Novartis](https://millionrounds.com/fund/novartis) [Longitude Capital](https://millionrounds.com/fund/longitude-capital) Source recorded SEC filing: $25M sold, first sale Aug 2023 - **Aug 2023** Round **$50M** *1 new* *4 returning* [Fidelity](https://millionrounds.com/fund/fidelity) [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [Novartis](https://millionrounds.com/fund/novartis) [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) Source recorded SEC filing: $25M sold, first sale Aug 2023 - **Apr 2019** Series C **$142M** *8 new* Novartis Pharma AG Lead [Longitude Capital](https://millionrounds.com/fund/longitude-capital) [Boxer Capital](https://millionrounds.com/fund/boxer-capital) [Perceptive Ventures](https://millionrounds.com/fund/perceptive-ventures) [Malin Corporation](https://millionrounds.com/fund/malin-corporation) Aisling Pentwater Vivo Reported by FinSMEs SEC filing: $142M sold, first sale Mar 2019 ## Founders and team From the SEC filings it signed: 5 on the team. - **Brent J. Warner** Executive Officer i - **Harry J. Leonhardt** Executive Officer i - **Johanna M. Mylet** Executive Officer i - **Kristin J. Yarema** Executive Officer i - **Mark J. Gergen** Executive Officer, Director i On the board, as filed i *Charles M. Baum* *Cynthia M. Collins* *John B. Schmid* *Luke M. Corning* *Marcea B. Lloyd* *Rafael J. Amado* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series C** 2019 **Round** 2023 **Round** 2023 [Fidelity](https://millionrounds.com/fund/fidelity) [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [Novartis](https://millionrounds.com/fund/novartis) [Longitude Capital](https://millionrounds.com/fund/longitude-capital) Novartis Pharma AG L [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) [Boxer Capital](https://millionrounds.com/fund/boxer-capital) [Perceptive Ventures](https://millionrounds.com/fund/perceptive-ventures) [Malin Corporation](https://millionrounds.com/fund/malin-corporation) ## Everyone who backed them [Fidelity](https://millionrounds.com/fund/fidelity) VC firm **2** rounds [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) Asset manager **2** rounds [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **2** rounds [Novartis](https://millionrounds.com/fund/novartis) VC firm **2** rounds [Longitude Capital](https://millionrounds.com/fund/longitude-capital) VC firm **2** rounds Novartis Pharma AG no record of our own yet **1** round, led 1 [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) Asset manager **1** round [Boxer Capital](https://millionrounds.com/fund/boxer-capital) VC firm **1** round [Perceptive Ventures](https://millionrounds.com/fund/perceptive-ventures) VC firm **1** round [Malin Corporation](https://millionrounds.com/fund/malin-corporation) Growth equity **1** round Aisling no record of our own yet **1** round Pentwater no record of our own yet **1** round Vivo no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=poseida-therapeutics). ## Also claim to have backed them This firm lists Poseida Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Aisling Capital](https://millionrounds.com/fund/aisling-capital) Private equity Per its own site ## Quick answers about Poseida Therapeutics ### Who invested in Poseida Therapeutics? Poseida Therapeutics's investors include Fidelity, Perceptive Advisors, Vivo Capital, Novartis and Longitude Capital, and 8 more on record. ### How much has Poseida Therapeutics raised? Poseida Therapeutics has raised $217M across 3 rounds since 2019. ### When did Poseida Therapeutics last raise? Poseida Therapeutics's most recent round was an Undisclosed round of $50M in Aug 2023. ### What was Poseida Therapeutics's biggest round? Poseida Therapeutics's largest round on record is $142M (Series C), in Apr 2019, led by Novartis Pharma AG. ### Who backed Poseida Therapeutics first? Poseida Therapeutics's first round on record, in Apr 2019, was backed by Novartis Pharma AG, Longitude Capital and Boxer Capital and 5 others. ### What stage is Poseida Therapeutics at? Poseida Therapeutics's latest named round is an Undisclosed round, in Aug 2023. ### Where is Poseida Therapeutics based? Poseida Therapeutics is based in the United States. ### Who led Poseida Therapeutics's rounds? Novartis Pharma AG led the Series C in 2019. ## Companies like Poseida Therapeutics In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app